These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 24887313

  • 1. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
    Dang NT, Sivakumaran H, Harrich D, Shaw PN, Davis-Poynter N, Coombes AG.
    Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission.
    Dang N, Sivakumaran H, Harrich D, Shaw PN, Coombes AGA.
    J Pharm Sci; 2014 Jul; 103(7):2107-2115. PubMed ID: 24867411
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.
    Dang NT, Sivakumaran H, Harrich D, Coombes AG.
    J Pharm Sci; 2013 Oct; 102(10):3725-35. PubMed ID: 23904196
    [Abstract] [Full Text] [Related]

  • 4. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.
    Dobard C, Sharma S, Martin A, Pau CP, Holder A, Kuklenyik Z, Lipscomb J, Hanson DL, Smith J, Novembre FJ, García-Lerma JG, Heneine W.
    J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766
    [Abstract] [Full Text] [Related]

  • 5. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir.
    Clark JT, Johnson TJ, Clark MR, Nebeker JS, Fabian J, Tuitupou AL, Ponnapalli S, Smith EM, Friend DR, Kiser PF.
    J Control Release; 2012 Oct 28; 163(2):240-8. PubMed ID: 22981701
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR, Friend DR.
    AIDS Res Hum Retroviruses; 2012 Nov 28; 28(11):1458-66. PubMed ID: 22394281
    [Abstract] [Full Text] [Related]

  • 7. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.
    Krogstad EA, Woodrow KA.
    Int J Pharm; 2014 Nov 20; 475(1-2):282-91. PubMed ID: 25169075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A, Devlin B, Cost M, Rohan LC.
    Mol Pharm; 2014 May 05; 11(5):1533-41. PubMed ID: 24693866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis.
    Pathak M, Turner M, Palmer C, Coombes AG.
    J Biomater Appl; 2014 Sep 05; 29(3):354-63. PubMed ID: 24682036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.
    Blakney AK, Krogstad EA, Jiang YH, Woodrow KA.
    Int J Nanomedicine; 2014 Sep 05; 9():2967-78. PubMed ID: 24971008
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design of tenofovir-UC781 combination microbicide vaginal gels.
    Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR.
    J Pharm Sci; 2012 May 05; 101(5):1852-64. PubMed ID: 22359356
    [Abstract] [Full Text] [Related]

  • 17. Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir.
    Kulkarni R, Feng JY, Miller MD, White KL.
    Antiviral Res; 2014 Jan 05; 101():131-5. PubMed ID: 24291780
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
    Dang NT, Turner MS, Coombes AG.
    J Biomater Appl; 2013 Jul 05; 28(1):74-83. PubMed ID: 22684517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.